Investigating long-term effects of sepsis in critically ill children
Official title: The Impact of Sepsis on Long-term Outcomes in Critical Ill Children With Sepsis
Run by West China Hospital · NCT06323226 · Data updated 2026-11-12
This study looks at how sepsis affects critically ill children over five years to see how it impacts their growth, brain development, survival, and quality of life after leaving the hospital.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Years to 16 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | West China Hospital Academic / other |
| Locations | 1 site (Chengdu, Sichuan) |
| Status | Recruiting |
| Started | January 1, 2019 |
| Main results expected | January 1, 2027 |
| Study ends | June 1, 2027 |
| Registry record updated | January 22, 2026 |
| Trial ID | NCT06323226 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are critically ill children under 16 years old who have been discharged from pediatric intensive care units after experiencing sepsis.
✕Probably not a fit
Patients with underlying diseases, cancer, or hematologic malignancies will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on critically ill children who have experienced sepsis, tracking their long-term outcomes over a five-year period. The research aims to assess various factors such as growth, neurodevelopment, survival rates, and quality of life following their discharge from pediatric intensive care units. A control group of matched children without underlying diseases will also be included for comparison. The study seeks to provide insights into the lasting impacts of sepsis on young patients.
Why it matters
Potential benefit: If successful, this study could enhance understanding of the long-term effects of sepsis in children, leading to improved care and support strategies.
How similar studies have gone: While there have been studies on sepsis outcomes, this specific long-term observational approach in critically ill children is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: We included critically ill children with sepsis who successfully discharged from pediatric Intensive care units, age \< 16 years. We also included age, sex, illness severity matched critically ill children as control group. Exclusion Criteria: We excluded children with underlying diseases, cancer, hematologic malignancy.
Where it's running
-
West China Hospital of Sichuan University
Chengdu, Sichuan, China Recruiting
Study contacts
- Study coordinator: Yi Ji, PhD, MD
- Email: jijiyuanyuan@163.com
- Phone: 8618980606865
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing blood purification methods in children with sepsis
This study is testing if starting continuous blood purification early can help children with sepsis recover better and reduce organ damage.
-
Ruta C and Vitamin C in Sepsis: Adding antioxidants to standard care
This trial tests whether adding Ruta C (rutin plus vitamin C) or vitamin C alone to standard sepsis treatment helps adults in the ICU stay shorter and recover better.
-
Early detection of sepsis-related blood clotting problems in severe burn patients
This study tests how well the JAAM-2 score can detect sepsis-induced coagulopathy early in adults with severe burns who develop sepsis in the ICU.
-
Neutrophil EMR3 as a biomarker for sepsis in ICU patients
Researchers will test whether measuring EMR3 on neutrophils helps diagnose sepsis, monitor progression, and predict outcomes in adults in Chinese ICUs.
-
Thymalfasin added to standard care for adults with sepsis and immune dysfunction
This study tests whether thymosin alpha-1 helps restore immune function in adults with sepsis who have weakened immunity.
-
Multicenter group study of sepsis and ARDS in China
This study tests how sepsis and ARDS differ among adults across several Chinese hospitals and builds a biobank to understand why some patients do better or worse.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.